Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

by Philippe Rochigneux, Jeanne Thomassin-Piana, Sophy Laibe, Serge Brunelle, Naji Salem, Bernard Escudier, Gilles Vassal, Gwenaelle Gravis
Published 2018-11-01

Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research

by Arthur Felix, Pablo Berlanga, Maud Toulmonde, Judith Landman‐Parker, Sarah Dumont, Gilles Vassal, Marie‐Cécile Le Deley, Nathalie Gaspar
Published 2021-03-01

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.

by Julie Liberman, Hervé Sartelet, Marjorie Flahaut, Annick Mühlethaler-Mottet, Aurélie Coulon, Carine Nyalendo, Gilles Vassal, Jean-Marc Joseph, Nicole Gross
Published 2012-01-01

GX15–070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma

by Sonia Cournoyer, Anissa Addioui, Assila Belounis, Mona Beaunoyer, Carine Nyalendo, Roxane Le Gall, Pierre Teira, Elie Haddad, Gilles Vassal, Hervé Sartelet
Published 2019-10-01

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.

by Estelle Daudigeos-Dubus, Ludivine Le Dret, Claudia Lanvers-Kaminsky, Olivia Bawa, Paule Opolon, Albane Vievard, Irène Villa, Mélanie Pagès, Jacques Bosq, Gilles Vassal, Dieter Zopf, Birgit Geoerger
Published 2015-01-01

Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.

by Matthieu Peyre, Frédéric Commo, Carmela Dantas-Barbosa, Felipe Andreiuolo, Stéphanie Puget, Ludovic Lacroix, Françoise Drusch, Véronique Scott, Pascale Varlet, Audrey Mauguen, Philippe Dessen, Vladimir Lazar, Gilles Vassal, Jacques Grill
Published 2010-09-01

The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.

by Roland Meier, Annick Mühlethaler-Mottet, Marjorie Flahaut, Aurélie Coulon, Carlo Fusco, Fawzia Louache, Katya Auderset, Katia Balmas Bourloud, Estelle Daudigeos, Curzio Ruegg, Gilles Vassal, Nicole Gross, Jean-Marc Joseph
Published 2007-01-01

Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.

by Valentina Boeva, Stéphanie Jouannet, Romain Daveau, Valérie Combaret, Cécile Pierre-Eugène, Alex Cazes, Caroline Louis-Brennetot, Gudrun Schleiermacher, Sandrine Ferrand, Gaëlle Pierron, Alban Lermine, Thomas Rio Frio, Virginie Raynal, Gilles Vassal, Emmanuel Barillot, Olivier Delattre, Isabelle Janoueix-Lerosey
Published 2013-01-01

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

by Antoine Italiano, Shivani Nanda, Andrew Briggs, Jesus Garcia-Foncillas, Ulrik Lassen, Gilles Vassal, Shivaani Kummar, Cornelis M. van Tilburg, David S. Hong, Theodore W. Laetsch, Karen Keating, John A. Reeves, Marc Fellous, Barrett H. Childs, Alexander Drilon, David M. Hyman
Published 2020-11-01

Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development.

by Dorine A Bax, Suzanne E Little, Nathalie Gaspar, Lara Perryman, Lynley Marshall, Marta Viana-Pereira, Tania A Jones, Richard D Williams, Anita Grigoriadis, Gilles Vassal, Paul Workman, Denise Sheer, Rui M Reis, Andrew D J Pearson, Darren Hargrave, Chris Jones
Published 2009-01-01

Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.

by Stephanie Puget, Cathy Philippe, Dorine A Bax, Bastien Job, Pascale Varlet, Marie-Pierre Junier, Felipe Andreiuolo, Dina Carvalho, Ricardo Reis, Lea Guerrini-Rousseau, Thomas Roujeau, Philippe Dessen, Catherine Richon, Vladimir Lazar, Gwenael Le Teuff, Christian Sainte-Rose, Birgit Geoerger, Gilles Vassal, Chris Jones, Jacques Grill
Published 2012-01-01

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report

by Diego Enrico, MD, Ludovic Lacroix, PharmD, PhD, Jeanne Chen, MD, Etienne Rouleau, PharmD, PhD, Jean-Yves Scoazec, MD, PhD, Yohann Loriot, MD, PhD, Lambros Tselikas, MD, Cécile Jovelet, PharmD, PhD, David Planchard, MD, PhD, Anas Gazzah, MD, Laura Mezquita, MD, PhD, Maud Ngo-Camus, MSc, Stefan Michiels, PhD, Christophe Massard, MD, PhD, Gonzalo Recondo, MD, PhD, Francesco Facchinetti, MD, Jordi Remon, MD, Jean-Charles Soria, MD, PhD, Fabrice André, MD, PhD, Gilles Vassal, MD, PhD, Luc Friboulet, PhD, Benjamin Besse, MD, PhD
Published 2020-06-01